Jenburkt Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

-

22.30

16.50

21.14

26.63

Net cashflow-operating activity

-

9.40

18.03

15.02

12.99

Net cash used in investing activity

-

-1.33

-18.78

-2.88

-10.53

Netcash used in fin. activity

-

-5.53

0.71

-10.83

-2.42

Net inc/dec in cash and equivlnt

-

2.54

-0.04

1.31

0.04

Cash and equivalnt begin of year

-

2.49

2.53

1.23

1.18

Cash and equivalnt end of year

-

5.03

2.49

2.53

1.23